- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05022251
Identifying Pain Generators and Potentiators of Residual Complaints Following Lumbar Discectomy (DISC-PAIN)
Lumbar discectomy (i.e. surgically removing a hernia) is frequently performed in Belgium to treat lumbar radiculopathy. Every year >12,000 interventions are performed with variable long-term results. The treatment success of this procedure varies and up to 41% of the patients report post-operative persistent pain complaints, and consequently suffer from failed back surgery syndrome (FBSS). Chronic complaints in FBSS following lumbar discectomy are usually treated with symptomatic interventions (including painkillers, neuromodulation, etc), rather than from a biopsychosocial perspective.
In order to develop a focused and effective treatment strategy, it is crucial to first gain insight into how persons with persistent complaints after lumbar discectomy differ from those without persistent symptoms. Different known contributing factors entail type of surgery, muscle and psychosocial impairments. Although in scientific and clinical literature it is assumed that dysfunctional pain processing also plays an important mechanistic role in FBSS, there is a lack of research to support this. However, this knowledge is crucial to depict the full mechanistic picture of pain generators and potentiators in FBSS.
Therefore, we will examine whether residual complaints persisting following lumbar discectomy can be accounted for by underlying dysfunctional pain processing and whether a clinical classification algorithm can be used to identify the predominant pain mechanism in these patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium
- Ghent University (Hospital)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Lumbar radiculopathy patients scheduled for first-time, single level, unilateral lumbar discectomy.
Sex, age, and BMI matched healthy controls.
Description
Inclusion Criteria:
- Dutch speaking
- Body mass index below 35kg/m²
- Lumbar radiculopathy patients, classified as ASA I to II without any symptoms of spinal cord compression (i.e. bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy
- Healthy, pain-free controls (score 0 on a visual analogue scale from 0 to 100)
Exclusion Criteria:
- Female participants will be excluded if pregnant, lactating or <1 year postnatal
- Having (a history) of severe medical disorders either respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurologic (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), endocrinological (e.g. diabetes), psychiatric (e.g. post-traumatic stress disorder
- Having a history of spinal surgery (e.g. discectomy), spinal traumata (e.g. vertebral fracture) or severe spinal deformities (e.g. spondylolisthesis)
- Having a pacemaker or defibrillator
- Healthy controls will be excluded if having suffered low back pain in the preceding year of score 2 or higher on the visual analog scale and which limited their activities of daily living or for which they consulted a (para)medic.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Lumbar radiculopathy
Lumbar radiculopathy patients (n=122), classified as ASA I to II without any symptoms of spinal cord compression (i.e.
bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy.
|
surgically removing a hernia
|
|
Healthy controls
Sex, age, and BMI-matched healthy, pain-free control subjects (n=122) will be recruited for study participation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative sensory testing (QST) - electrical detection threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n.
suralis and n. medianus, recorded in mA.
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - electrical pain threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n.
suralis and n. medianus, recorded in mA.
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - thermal detection threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C:
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - thermal pain threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C:
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - discrimination between thermal stimuli
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - tactile detection threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - mechanical pain threshold
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - sensitivity to pressure stimuli
Time Frame: Change from baseline (T1) at 3 months after surgery (T2)
|
Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg
|
Change from baseline (T1) at 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - temporal summation of electrical stimuli
Time Frame: Change from baseline (T1) and 3 months after surgery (T2)
|
Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded. |
Change from baseline (T1) and 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - temporal summation of mechanical stimuli
Time Frame: Change from baseline (T1) and 3 months after surgery (T2)
|
Determination of temporal summation in response to mechanical stimuli delivered using a 256mN pinprick stimulator. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded. |
Change from baseline (T1) and 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - spinal hyperexcitability
Time Frame: Change from baseline (T1) and 3 months after surgery (T2)
|
Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA
|
Change from baseline (T1) and 3 months after surgery (T2)
|
|
Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability
Time Frame: Change from baseline (T1) and 3 months after surgery (T2)
|
Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)
|
Change from baseline (T1) and 3 months after surgery (T2)
|
|
Quantitative sensory testing - conditioned pain modulation
Time Frame: Change from baseline (T1) and 3 months after surgery (T2)
|
Determination of condition pain modulation (aka.
pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm.
Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10.
Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.
|
Change from baseline (T1) and 3 months after surgery (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Central sensitization inventory
Time Frame: Baseline (T1)
|
Self-report measure of signs and symptoms associated with central sensitization
|
Baseline (T1)
|
|
Central sensitization inventory
Time Frame: 3 months after surgery (T2)
|
Self-report measure of signs and symptoms associated with central sensitization
|
3 months after surgery (T2)
|
|
Douleur Neuropathique 4 Questionnaire
Time Frame: Baseline (T1)
|
Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain
|
Baseline (T1)
|
|
Douleur Neuropathique 4 Questionnaire
Time Frame: 3 months after surgery (T2)
|
Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain
|
3 months after surgery (T2)
|
|
Pain catastrophizing scale
Time Frame: Baseline (T1)
|
Self-report measure of pain perceptions and cognitions
|
Baseline (T1)
|
|
Pain catastrophizing scale
Time Frame: 3 months after surgery (T2)
|
Self-report measure of pain perceptions and cognitions
|
3 months after surgery (T2)
|
|
Pain vigilance and awareness questionnaire
Time Frame: Baseline (T1)
|
Self-report measure assessing preoccupation with and attention to pain
|
Baseline (T1)
|
|
Pain vigilance and awareness questionnaire
Time Frame: 3 months after surgery (T2)
|
Self-report measure assessing preoccupation with and attention to pain
|
3 months after surgery (T2)
|
|
Oswestry disability index
Time Frame: Baseline (T1)
|
Self-report measure evaluating low back pain related disability
|
Baseline (T1)
|
|
Oswestry disability index
Time Frame: 3 months after surgery (T2)
|
Self-report measure evaluating low back pain related disability
|
3 months after surgery (T2)
|
|
Tampa scale for kinesiophobia
Time Frame: Baseline (T1)
|
Self-report measure assessing fear of movement
|
Baseline (T1)
|
|
Tampa scale for kinesiophobia
Time Frame: 3 months after surgery (T2)
|
Self-report measure assessing fear of movement
|
3 months after surgery (T2)
|
|
International physical activity questionnaire
Time Frame: Baseline (T1)
|
Self-report measure of physical activity in preceeding 7 days
|
Baseline (T1)
|
|
International physical activity questionnaire
Time Frame: 3 months after surgery (T2)
|
Self-report measure of physical activity in preceeding 7 days
|
3 months after surgery (T2)
|
|
Patient-reported outcomes measurement information system
Time Frame: Baseline (T1)
|
Self-report measure of health-related domains including:
|
Baseline (T1)
|
|
Patient-reported outcomes measurement information system
Time Frame: 3 months after surgery (T2)
|
Self-report measure of health-related domains including:
|
3 months after surgery (T2)
|
|
Brief Illness Perception Questionnaire
Time Frame: Baseline (T1)
|
Self-report measure evaluating illness perceptions
|
Baseline (T1)
|
|
Brief Illness Perception Questionnaire
Time Frame: 3 months after surgery (T2)
|
Self-report measure evaluating illness perceptions
|
3 months after surgery (T2)
|
|
Pain Coping Inventory
Time Frame: Baseline (T1)
|
Self-report measure assessing pain coping strategies
|
Baseline (T1)
|
|
Pain Coping Inventory
Time Frame: 3 months after surgery (T2)
|
Self-report measure assessing pain coping strategies
|
3 months after surgery (T2)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jessica Van Oosterwijck, PhD, Ghent University; Research Foundation Flanders
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BC-08041
- 3F014119 (Other Grant/Funding Number: Research Foundation - Flanders (FWO))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Radiculopathy
-
Cairo UniversityCompletedLumbosacral Radiculopathy | Lumbar Radiculopathy Due to Spinal Nerve Compression | Lumbar Disc Prolapse With Radiculopathy | LUMBAR RADICULOPATHYEgypt
-
Providence Medical Technology, Inc.RecruitingRadiculopathy Lumbar | Degenerative Lumbar Disc DiseaseUnited States
-
October 6 UniversityCompleted
-
American University of Beirut Medical CenterQuantel MedicalNot yet recruitingRadiculopathy Lumbar | Disc Disease LumbarLebanon
-
NeuFit - Neurological Fitness and EducationRecruitingRadiculopathy Lumbar | Radiculopathy Sacral | Radiculopathy Multiple SitesUnited States
-
Izmir City HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Khyber Medical University PeshawarKMU-Institute of Health Sciences, IslamabadRecruiting
-
Marmara UniversityNot yet recruitingLumbar Disc Herniation | Radiculopathy LumbarTurkey
-
National University of Natural MedicineRecruitingLumbar RadiculopathyUnited States
Clinical Trials on Lumbar discectomy
-
Al-Azhar UniversityRecruitingDiabetes Mellitus | Open | Lumbar Discectomy | EndoscopeEgypt
-
University of OpoleActive, not recruitingLumbar Radiculopathy | Sciatic Nerve Compression | Discopathy | Disc Herniation | Disc Herniation With Radiculopathy | Lumbar Degenerative Disease | Sciatic Leg PainPoland
-
Saglik Bilimleri UniversitesiCompletedDisplacement of Intervertebral Disc Without MyelopathyTurkey
-
Centre Hospitalier Régional de la CitadelleJM Remacle, MD, Head of Neurosurgery Department, CHR Citadelle; Vincent Bonhomme...Unknown
-
Greenwich HospitalAmerican Association of Neurological SurgeonsCompletedSymptomatic Lumbar Disc Herniation | Symptomatic Grade I Lumbar SpondylolisthesisUnited States, Canada
-
Sohag UniversityNot yet recruitingLumbar Disc HerniationEgypt
-
State University of New York - Upstate Medical...Terminated
-
Assiut UniversityCompletedLumbar Disc Herniation
-
Second Affiliated Hospital of Wenzhou Medical UniversityCompletedLumbar Spinal Stenosis | Degeneration Disc
-
Yale UniversityUniversity of Washington; University of New Mexico; Desert Institute for Spine... and other collaboratorsTerminatedLumbar Disc HerniationUnited States